The role of Fhit protein in the oncogenesis of colorectal cancer is still in debate. Recent studies have revealed that reduced Fhit protein expression is associated with a deficiency of the mismatch repair protein. One hundred and twenty unselected patients who underwent curative resection for sporadic colorectal cancer in a three-year period were evaluated for microsatellite instability (MSI) using six microsatellite markers, and for the presence of Fhit and mismatch repair (MMR) proteins (Mlh1 and Msh2) by means of immunostaining. The relations between these markers were analysed. Reduced or absent Fhit expression was noted in 18 out of 118 patients. This altered expression was significantly higher in right-sided cancer (P = 0.005), mucinous tumours (P = 0.005) and in poorly differentiated histological types (P = 0.0001). MSI was found in 22 out of 109 patients, more so in right-sided cancer (P = 0.0001), poorly differentiated histology (P = 0.0001), and mucinous tumours (P = 0.0001). No association was found with TNM stage. MSI was present in 66.7% of tumours with altered Fhit expression and in only 10% of tumours with preserved or intermediate Fhit expression (P = 0.0001). Of the tumours with reduced or absent Fhit expression, 72.2% had loss of nuclear Mlh1 or Msh2 expression compared with only 14% of the preserved or intermediate Fhit expression tumours (P = 0.0001). These results support the hypothesis that deficiency in a MMR gene could be a cause of the high frequency of alterations in Fhit expression, and they permit the suggestion that FHIT gene alteration may be part of the genetic pathway involving MSI through which some colorectal cancers arise.

Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancer / Sarli, Leopoldo; Bottarelli, L.; Azzoni, C.; Campanini, N.; DI COLA, G.; Bader, G.; Iusco, D.; Salvemini, C.; Caruso, G.; Donadei, E.; Pizzi, S.; D'Adda, Tiziana; Costi, Renato; Roncoroni, Luigi; Bordi, C.. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - 40:(2004), pp. 1581-1588. [10.1016/j.ejca.2004.02.021]

Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancer

SARLI, Leopoldo;D'ADDA, Tiziana;COSTI, Renato;RONCORONI, Luigi;
2004

Abstract

The role of Fhit protein in the oncogenesis of colorectal cancer is still in debate. Recent studies have revealed that reduced Fhit protein expression is associated with a deficiency of the mismatch repair protein. One hundred and twenty unselected patients who underwent curative resection for sporadic colorectal cancer in a three-year period were evaluated for microsatellite instability (MSI) using six microsatellite markers, and for the presence of Fhit and mismatch repair (MMR) proteins (Mlh1 and Msh2) by means of immunostaining. The relations between these markers were analysed. Reduced or absent Fhit expression was noted in 18 out of 118 patients. This altered expression was significantly higher in right-sided cancer (P = 0.005), mucinous tumours (P = 0.005) and in poorly differentiated histological types (P = 0.0001). MSI was found in 22 out of 109 patients, more so in right-sided cancer (P = 0.0001), poorly differentiated histology (P = 0.0001), and mucinous tumours (P = 0.0001). No association was found with TNM stage. MSI was present in 66.7% of tumours with altered Fhit expression and in only 10% of tumours with preserved or intermediate Fhit expression (P = 0.0001). Of the tumours with reduced or absent Fhit expression, 72.2% had loss of nuclear Mlh1 or Msh2 expression compared with only 14% of the preserved or intermediate Fhit expression tumours (P = 0.0001). These results support the hypothesis that deficiency in a MMR gene could be a cause of the high frequency of alterations in Fhit expression, and they permit the suggestion that FHIT gene alteration may be part of the genetic pathway involving MSI through which some colorectal cancers arise.
Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancer / Sarli, Leopoldo; Bottarelli, L.; Azzoni, C.; Campanini, N.; DI COLA, G.; Bader, G.; Iusco, D.; Salvemini, C.; Caruso, G.; Donadei, E.; Pizzi, S.; D'Adda, Tiziana; Costi, Renato; Roncoroni, Luigi; Bordi, C.. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - 40:(2004), pp. 1581-1588. [10.1016/j.ejca.2004.02.021]
File in questo prodotto:
File Dimensione Formato  
Sarli-6.pdf

non disponibili

Tipologia: Altro materiale allegato
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 184.58 kB
Formato Adobe PDF
184.58 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2298567
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 24
social impact